Sterol structure dependence of insulin receptor and insulin-like growth factor 1 receptor activation

被引:24
|
作者
Delle Bovi, Richard J. [1 ]
Kim, JiHyun [2 ]
Suresh, Pavana [2 ]
London, Erwin [2 ]
Miller, W. Todd [1 ,3 ]
机构
[1] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA
[3] Dept Vet Affairs Med Ctr, Northport, NY 11768 USA
来源
关键词
Receptor tyrosine kinase; Cholesterol; Autophosphorylation; LIGAND-INDEPENDENT ACTIVATION; DOMAINS LIPID RAFTS; PLASMA-MEMBRANE; CHOLESTEROL DEPLETION; GLUCOSE-UPTAKE; PRAVASTATIN; PROTEINS; CAVEOLAE; PURIFICATION; QUANTITATION;
D O I
10.1016/j.bbamem.2019.01.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The plasma membrane is a dynamic environment with a complex composition of lipids, proteins, and cholesterol. Areas enriched in cholesterol and sphingolipids are believed to form lipid rafts, domains of highly ordered lipids. The unique physical properties of these domains have been proposed to influence many cellular processes. Here, we demonstrate that the activation of insulin receptor (IR) and insulin-like growth factor 1 receptor (IGF1R) depends critically on the structures of membrane sterols. IR and IGF1R autophosphorylation in vivo was inhibited by cholesterol depletion, and autophosphorylation was restored by the replacement with exogenous cholesterol. We next screened a variety of sterols for effects on IR activation. The ability of sterols to support IR autophosphorylation was strongly correlated to the propensity of the sterols to form ordered domains. IR autophosphorylation was fully restored by the incorporation of ergosterol, dihydrocholesterol, 7-dehydrocholesterol, lathosterol, desmosterol, and allocholesterol, partially restored by epicholesterol, and not restored by lanosterol, coprostanol, and 4-cholesten-3-one. These data support the hypothesis that the ability to form ordered domains is sufficient for a sterol to support ligand-induced activation of IR and IGF1R in intact mammalian cells.
引用
收藏
页码:819 / 826
页数:8
相关论文
共 50 条
  • [11] Structure and function of the type 1 insulin-like growth factor receptor
    Adams, TE
    Epa, VC
    Garrett, TPJ
    Ward, CW
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (07) : 1050 - 1093
  • [12] The contradictions of the insulin-like growth factor 1 receptor
    Baserga, R
    ONCOGENE, 2000, 19 (49) : 5574 - 5581
  • [13] The contradictions of the insulin-like growth factor 1 receptor
    Renato Baserga
    Oncogene, 2000, 19 : 5574 - 5581
  • [14] Structural basis of the activation of type 1 insulin-like growth factor receptor
    Li, Jie
    Choi, Eunhee
    Yu, Hongtao
    Bai, Xiao-chen
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [15] Structural basis of the activation of type 1 insulin-like growth factor receptor
    Jie Li
    Eunhee Choi
    Hongtao Yu
    Xiao-chen Bai
    Nature Communications, 10
  • [16] Implications of Insulin-like Growth Factor 1 Receptor Activation in Lung Cancer
    Nurwidya, Fariz
    Andarini, Sita
    Takahashi, Fumiyuki
    Syahruddin, Elisna
    Takahashi, Kazuhisa
    MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2016, 23 (03): : 9 - 21
  • [17] Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
    Tian, Dan
    Mitchell, Isaiah
    Kreeger, Pamela K.
    BMC SYSTEMS BIOLOGY, 2016, 10
  • [18] Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
    Belfiore, Antonino
    Frasca, Francesco
    Pandini, Giusepe
    Sciacca, Laura
    Vigneri, Riccardo
    ENDOCRINE REVIEWS, 2009, 30 (06) : 586 - 623
  • [19] Structure and function of the insulin-like growth factor I receptor
    Sepp-Lorenzino, L
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 47 (03) : 235 - 253
  • [20] LINSITINIB Insulin-like Growth Factor 1 Receptor Antagonist Insulin Receptor Antagonist Oncolytic
    Bowles, Daniel W.
    Kessler, Elizabeth R.
    Jimeno, Antonio
    DRUGS OF THE FUTURE, 2011, 36 (12) : 881 - 891